MDMA-Assisted Therapy for PTSD: Open-Label Lead-In Study – Timeline

Phase 2 Open-Label Lead-In Study of MDMA-Assisted Therapy for PTSD: Database Interim Locked

December 26, 2019
Phase 2 Open-Label Lead-In Study of MDMA-Assisted Therapy for PTSD: Data Under Review

December 11, 2019
Open-Label Lead-In Study of MDMA-Assisted Therapy for PTSD: All Sites Fully Enrolled

April 3, 2019
Open-Label Lead-In Study of MDMA-Assisted Therapy for PTSD: 30th Participant Completes Treatment

March 6, 2019
Open-Label Lead-In Study of MDMA-Assisted Therapy for PTSD: 29th Participant Completes Treatment

February 19, 2019
Open-Label Lead-In Study of MDMA-Assisted Therapy for PTSD: 26th Participant Completes Treatment

January 16, 2019
Open-Label Lead-In Study of MDMA-Assisted Therapy for PTSD: 25th Participant Completes Treatment

December 21, 2018
Open-Label Lead-In Study of MDMA-Assisted Therapy for PTSD: 23rd Participant Completes Treatment

November 22, 2018